Actively Recruiting

Age: 29Days - 18Years
All Genders
NCT04850456

Treatment Strategy of Human Gamma Globulin on the Therapy for Intensively Ill Children With Inflammatory Storm

Led by Children's Hospital of Fudan University · Updated on 2026-03-16

200

Participants Needed

2

Research Sites

117 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The inflammatory storm in critically ill patients releases cytokines, causing systemic immune damage, which may be an important cause of multiple organ failure and even death. Inflammatory storms exacerbate the deterioration of the disease in those children. Gamma globulin may be an effective option to control inflammatory storms. However, this preliminary result needs to be verified from reliable and representative RCTs. In our study, we conducted a retrospective study on the use of gamma globulin and an unused control group. At present, the indications of IVIG are mainly focused on the neuromuscular system and the blood system. We hope to establish a more appropriate and operable evaluation table for the suitability of gamma globulin for clinical use.

CONDITIONS

Official Title

Treatment Strategy of Human Gamma Globulin on the Therapy for Intensively Ill Children With Inflammatory Storm

Who Can Participate

Age: 29Days - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Children hospitalized in the Pediatric Intensive Care Unit (PICU) of Children's Hospital of Fudan University
  • Children with severe infection complicated with inflammatory storm
Not Eligible

You will not qualify if you...

  • Discharge within 48 hours
  • Patients without informed consent
  • Incomplete clinical and demographic data

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Children's Hospital of Fudan University

Shanghai, Shanghai Municipality, China

Actively Recruiting

2

Children's Hospital of Fudan University

Shanghai, China, 201102

Actively Recruiting

Loading map...

Research Team

G

Guoping Lu, Doctor

CONTACT

Y

Yao Wang

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here